跳至主要内容
临床试验/IRCT20130911014630N6
IRCT20130911014630N6招募中早期 1 期

Evaluation of Therapeutic Effect of glucoseinolate extract of Descurainia sophia (L.) Webb ex Prantl on the improvement of patients with hyperthyroidism who are treated with methimazole;Pilot study Double Blinded and Placebo-Controlled Clinical Trial

Sari University of Medical Sciences0 个研究点目标入组 16 人开始时间: 待定最近更新:

试验速览

阶段
早期 1 期
状态
招募中
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
Female

入选标准

  • Age between twenty to sixty years
  • Patients with a higher level of FT4 hormones have a parity of 17 pg /L
  • Patients with a FT3 serum level Larger than equal to 5.7 pg/ml
  • Patients with a lower serum TSH level equal to MU / I0.4

排除标准

  • Patients with a history of underlying illness, such as diabetes or hypertension or liver failure, such as cirrhosis of the liver and kidney or heart disease, according to patients referenced
  • Use other medications
  • Use cigarettes right now
  • Pregnant patients
  • Lactating patients
  • Patients who have taken an antithyroid drug for the last three months
  • Patient with ALT levels are twice the normal range
  • Patients who are required to receive other medications for the treatment of other illness during the study
  • Patients who experience side effects such as itching or headache or allergies to the drug
  • Requesting a patient or his family to leave the study

研究者

发起方
Sari University of Medical Sciences

相似试验